Efficacy of co-trimoxazole in Donovanosis. A preliminary report.
AUTOR(ES)
Garg, B R
RESUMO
Co-trimoxazole (Septrin, Wellcome) was prescribed in a dose of two tablets twice daily for the treatment of 10 patients with Donovanosis. All the patients responded well to this treatment, and the ulcers healed completely within 10 days in eight patients and within 14 days in the remaining two. Ten days' treatment with 40 tablets of co-trimoxazole is suggested as sufficient to treat Donovanosis. No adverse reactions were noted in any patient.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045539Documentos Relacionados
- Further evidence of the efficacy of co-trimoxazole in granuloma venereum.
- Increasing Resistance of Brucellae to Co-Trimoxazole
- Co-trimoxazole in rheumatoid arthritis: a comparison with sulphapyridine.
- Efficacy of oral treatment with acyclovir and co-trimoxazole in first episode genital herpes.
- Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis.
